A private company advising the agency that oversees Medicare has recommended against reimbursing for the biomarker tests, ...

China's first such test since 2024 took place amid warnings from Australia and New Zealand.

GRAIL is the only company that has applied for MCED FDA premarket approval so far; if approved by the FDA and covered by ...

Many people put off buying health insurance because they feel healthy. It is easy to see why. When there are no immediate ...

Around 1 in 10 people who get sick with Legionnaires' disease will die due to complications like lung failure, per the CDC.

Bernstein lifted its Guardant Health price target to $200 after UnitedHealth's Shield coverage decision. Here's what it means for GH investors.

The right accessibility testing tools help organisations catch issues early, improve usability, and build products that work ...

Preeclampsia is a leading cause of death in pregnancy, and Illinois Gov. JB Pritzker is now requiring insurance to cover ...

Space Exploration Technologies Corp. (NASDAQ:SPCX) is one of the 14 AI Stocks Making Moves on Wall Street: Nvidia, Micron, ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered by GENFIT’s proprietary NIS4® technologyFocuses on ...